2021 National Survey on Prior Authorization Burden and Its Impact on Gastroenterology Practice.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35296630.
- Also identified by DOI 10.14309/ajg.0000000000001728 and PMC identifier 9060934.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prior authorizations (PAs) are intended to control prescription drug expenditures. One hundred fifty-six physician and advanced practice provider members of the American College of Gastroenterology completed a national survey to assess PA burden and impact. One-half of PA requests relate to prescription refills. Greater than 50% of the respondents choose inferior treatments at least weekly because of perceived PA burden for preferred agents. One-half of the respondents reported a patient who experienced serious adverse events due to PA-related care delays. PA is an administrative burden that exhausts practice resources and may have a negative impact on patient care.
Medical subject headings
- Gastroenterology
- Prescription Drugs